169 related articles for article (PubMed ID: 26299935)
1. Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer.
Zhang L; Guo M; Li J; Zheng Y; Zhang S; Xie T; Liu B
Mol Biosyst; 2015 Nov; 11(11):2860-6. PubMed ID: 26299935
[TBL] [Abstract][Full Text] [Related]
2. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
[No Abstract] [Full Text] [Related]
3. A novel ATG4B antagonist inhibits autophagy and has a negative impact on osteosarcoma tumors.
Akin D; Wang SK; Habibzadegah-Tari P; Law B; Ostrov D; Li M; Yin XM; Kim JS; Horenstein N; Dunn WA
Autophagy; 2014; 10(11):2021-35. PubMed ID: 25483883
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.
Fu Y; Hong L; Xu J; Zhong G; Gu Q; Gu Q; Guan Y; Zheng X; Dai Q; Luo X; Liu C; Huang Z; Yin XM; Liu P; Li M
Autophagy; 2019 Feb; 15(2):295-311. PubMed ID: 30176161
[TBL] [Abstract][Full Text] [Related]
5. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer.
Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH
Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540
[TBL] [Abstract][Full Text] [Related]
6. SLC27A4 regulate ATG4B activity and control reactions to chemotherapeutics-induced autophagy in human lung cancer cells.
Wu S; Su J; Qian H; Guo T
Tumour Biol; 2016 May; 37(5):6943-52. PubMed ID: 26662804
[TBL] [Abstract][Full Text] [Related]
7. Identification of breast cancer cell subtypes sensitive to ATG4B inhibition.
Bortnik S; Choutka C; Horlings HM; Leung S; Baker JH; Lebovitz C; Dragowska WH; Go NE; Bally MB; Minchinton AI; Gelmon KA; Gorski SM
Oncotarget; 2016 Oct; 7(41):66970-66988. PubMed ID: 27556700
[TBL] [Abstract][Full Text] [Related]
8. Context-dependent role of ATG4B as target for autophagy inhibition in prostate cancer therapy.
Tran E; Chow A; Goda T; Wong A; Blakely K; Rocha M; Taeb S; Hoang VC; Liu SK; Emmenegger U
Biochem Biophys Res Commun; 2013 Nov; 441(4):726-31. PubMed ID: 24184480
[TBL] [Abstract][Full Text] [Related]
9. Targeting the MIR34C-5p-ATG4B-autophagy axis enhances the sensitivity of cervical cancer cells to pirarubicin.
Wu Y; Ni Z; Yan X; Dai X; Hu C; Zheng Y; He F; Lian J
Autophagy; 2016 Jul; 12(7):1105-17. PubMed ID: 27097054
[TBL] [Abstract][Full Text] [Related]
10. Targeting Atg4B for cancer therapy: Chemical mediators.
Yang G; Li Y; Zhao Y; Ouyang L; Chen Y; Liu B; Liu J
Eur J Med Chem; 2021 Jan; 209():112917. PubMed ID: 33077263
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor screening and enzymatic activity determination for autophagy target Atg4B using a gel electrophoresis-based assay.
Cleenewerck M; Grootaert MOJ; Gladysz R; Adriaenssens Y; Roelandt R; Joossens J; Lambeir AM; De Meyer GRY; Declercq W; Augustyns K; Martinet W; Van der Veken P
Eur J Med Chem; 2016 Nov; 123():631-638. PubMed ID: 27517808
[TBL] [Abstract][Full Text] [Related]
12. [Flubendazole Inhibits the Proliferation of A549 and H460 Cells and Promotes Autophagy].
Dong T; Lu Z; Li J; Liu Y; Wen J
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):306-313. PubMed ID: 32429634
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated TMED10 in Alzheimer disease induces autophagy via ATG4B activation.
Shin JH; Park SJ; Jo DS; Park NY; Kim JB; Bae JE; Jo YK; Hwang JJ; Lee JA; Jo DG; Kim JC; Jung YK; Koh JY; Cho DH
Autophagy; 2019 Sep; 15(9):1495-1505. PubMed ID: 30821607
[TBL] [Abstract][Full Text] [Related]
14. On ATG4B as Drug Target for Treatment of Solid Tumours-The Knowns and the Unknowns.
Agrotis A; Ketteler R
Cells; 2019 Dec; 9(1):. PubMed ID: 31878323
[TBL] [Abstract][Full Text] [Related]
15. ATG4B inhibitors with a benzotropolone core structure block autophagy and augment efficiency of chemotherapy in mice.
Kurdi A; Cleenewerck M; Vangestel C; Lyssens S; Declercq W; Timmermans JP; Stroobants S; Augustyns K; De Meyer GRY; Van Der Veken P; Martinet W
Biochem Pharmacol; 2017 Aug; 138():150-162. PubMed ID: 28642033
[TBL] [Abstract][Full Text] [Related]
16. Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy.
Lin S; Yang L; Yao Y; Xu L; Xiang Y; Zhao H; Wang L; Zuo Z; Huang X; Zhao C
J Exp Clin Cancer Res; 2019 Jul; 38(1):293. PubMed ID: 31287013
[TBL] [Abstract][Full Text] [Related]
17. JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells.
Li Y; Luo Q; Yuan L; Miao C; Mu X; Xiao W; Li J; Sun T; Ma E
Toxicol Appl Pharmacol; 2012 Aug; 263(1):21-31. PubMed ID: 22668848
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a Small-Molecule Bromodomain-Containing Protein 4 (BRD4) Inhibitor That Induces AMP-Activated Protein Kinase-Modulated Autophagy-Associated Cell Death in Breast Cancer.
Ouyang L; Zhang L; Liu J; Fu L; Yao D; Zhao Y; Zhang S; Wang G; He G; Liu B
J Med Chem; 2017 Dec; 60(24):9990-10012. PubMed ID: 29172540
[TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing Screening Identifies Tioconazole as an ATG4 Inhibitor that Suppresses Autophagy and Sensitizes Cancer Cells to Chemotherapy.
Liu PF; Tsai KL; Hsu CJ; Tsai WL; Cheng JS; Chang HW; Shiau CW; Goan YG; Tseng HH; Wu CH; Reed JC; Yang LW; Shu CW
Theranostics; 2018; 8(3):830-845. PubMed ID: 29344310
[No Abstract] [Full Text] [Related]
20. ATG4B inhibitor FMK-9a induces autophagy independent on its enzyme inhibition.
Chu J; Fu Y; Xu J; Zheng X; Gu Q; Luo X; Dai Q; Zhang S; Liu P; Hong L; Li M
Arch Biochem Biophys; 2018 Apr; 644():29-36. PubMed ID: 29510087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
